Boron distribution in the normal rat brain after intravenous injection of boronophenylalanine-fructose
Access this Article
Search this Article
Boron neutron capture therapy (BNCT) is an experimental form of radiation therapy for malignant brain tumors and peripheral melanoma. The micro-distribution of the boron compound is critical to determine the radiation effects for both tumors and normal tissue. In the current dose calculation of BNCT, normal brain tissue is considered to have a homogeneous boron concentration. The purpose of this study was to examine the structure-specific boron concentration in normal rat neural tissue. At 10, 30 and 60 min after intravenous injection of 300 mg/kg boronophenylalanine-fructose to 10-week-old CD Fisher rats, neural tissue and blood were collected. Various neural structures were anatomically and histologically identified and specific boron concentrations were analyzed using high-resolution quantitative autoradiography. At 60 min after the injection, only the pituitary gland showed a higher boron concentration than that in blood, with the former being threefold higher. All other neural structures showed lower boron concentrations than that in blood. The present study thus demonstrated an extremely high boron concentration in the pituitary gland following intravenous injection of boronophenylalanine-fructose. In clinical trials of BNCT using an epithermal neutron beam, the radiation dose to the pituitary gland should be carefully evaluated.
- Journal of neuro-oncology
Journal of neuro-oncology 87(1), 35-41, 2008-03